Ownership

LiPlasome Pharma A/S was incepted in 2002 and in 2010 VECATA acquired all rights to what is now LiPlasome Pharma ApS. 

Owner
 

Shareholders

 

Major shareholder:
VECATA A/S

Others:
East West Capital
Buhl Oncology